Agreement renews Ohio rebates for drug overdose antidote


COLUMBUS, Ohio (AP) — Ohio Attorney General Mike DeWine has announced a year-long extension of a deal with a drug overdose antidote manufacturer to provide rebates for public agencies buying the drug.

California-based Amphastar Pharmaceuticals Inc. is the maker of naloxone (nuh-LOX’-ohn). DeWine asked Amphastar for the rebates last year after the cost of supplies of the drug nearly doubled.

Under the deal announced on Tuesday, Amphastar will continue providing a $6 rebate for each naloxone syringe bought by a non-federal public entity in Ohio in the next 12 months.

DeWine says nearly 60 Ohio agencies have applied for more than $151,000 in rebates to offset the cost of the life-saving drug.

The Ohio Department of Public Safety says naloxone was administered more than 16,000 times in Ohio in 2015.